Relevant bibliographies by topics / Arthritis Prognosis

Academic literature on the topic 'Arthritis Prognosis'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Arthritis Prognosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Arthritis Prognosis"

1

ODEWUSI, OO, MJ ABDULMUMIN, and OO OLANIYAN. "AN ASSESSMENT OF AUTOIMMUNITY IN ARTHRITIS PATIENTS." International Journal of Medical Laboratory Research 07, no. 01 (2022): 53–61. http://dx.doi.org/10.35503/ijmlr.2022.7108.

Full text
Abstract:
Objectives: The goal of this study is to estimate autoimmune biomarkers that characterize the development and severity of arthritis, but probably normalize following successful therapy. Materials and methods: In this study a total of 109 subjects were used out of which treated and untreated arthritics were 48 and 44 respectively, the remaining 17 were healthy individuals which were used as control. Samples were collected from patients attending Rheumatology and Orthopedic clinic of Federal Teaching Hospital Ido-ekiti, Ekiti State Nigeria. Antinuclear antibody was estimated using Enzyme Linked Immunosorbent Assay (ELISA) while Lupus Erythematosus cells were ascertained microscopically using Leishman staining technique. All parameters were assessed in treated and untreated arthritic patients relative to healthy subjects. Body mass index was also calculated. Statistical analysis was done using SPSS. Results: Body mass index and Antinuclear antibodies were significantly higher in treated and untreated arthritics compared to control (P<0.05). When treated and untreated arthritics were compared, Body mass index and Antinuclear antibody were found to be significantly higher in untreated arthritics (P<0.05). Antinuclear antibody and Age correlated directly in untreated arthritics. Lupus Erythematosus cell prevalence was found to be higher in untreated arthritics having a percentage Lupus Erythematosus test positivity of 6.8% compared to the 2.1% seen in treated arthritics. Conclusion: It was found that Autoimmunity in arthritics can be significantly lowered through treatment with Arthritic drugs, diets, life style modifications over a period of time. The study suggests that Antinuclear antibody and Lupus Erythematosus estimations could be adopted as markers of diagnosis, prognosis and monitoring of arthritis.
APA, Harvard, Vancouver, ISO, and other styles
2

Weisman, Michael H. "Prognosis in rheumatoid arthritis." Current Opinion in Rheumatology 2, no. 3 (June 1990): 458–62. http://dx.doi.org/10.1097/00002281-199002030-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

WORCESTER, SHARON. "Childhood Arthritis Prevalence, Prognosis Eyed." Pediatric News 41, no. 6 (June 2007): 36. http://dx.doi.org/10.1016/s0031-398x(07)70386-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

MAHONEY, DIANA. "Lyme Arthritis: Accurate Dx Improves Prognosis." Family Practice News 41, no. 5 (March 2011): 38–39. http://dx.doi.org/10.1016/s0300-7073(11)70253-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Druce, Katie L., and Neil Basu. "Predictors of fatigue in rheumatoid arthritis." Rheumatology 58, Supplement_5 (November 1, 2019): v29—v34. http://dx.doi.org/10.1093/rheumatology/kez346.

Full text
Abstract:
Abstract People with RA commonly experience fatigue. Fatigue is a key contributor to increased clinical care costs, primary care consultations and employment loss. Despite this, our understanding of the prognostic of factors of poor fatigue outcomes is lacking and fatigue is poorly managed. Examining longitudinal predictors of fatigue can identify both individuals ‘at risk’ of poor prognosis, and candidate mechanisms that are worthy of greater inspection. This review discusses the factors most commonly investigated as being implicated in the prognosis of RA fatigue. The available data appears to implicate generic factors such as pain, mental health, disability and sleep as consistent predictors of fatigue outcome, while the role of disease activity and inflammation seems less clear. However, the existing data are not without methodological limitations and there have been no specific studies primarily designed to investigate the inflammatory biomarkers of fatigue. Future studies are required to more comprehensively and robustly determine the mechanisms of fatigue.
APA, Harvard, Vancouver, ISO, and other styles
6

Cho, Byung-Ki, and Seung-myung Choi. "Prognosis of Medial Gutter Osteoarthritis Combined with Chronic Ankle Instability." Foot & Ankle Orthopaedics 3, no. 3 (July 1, 2018): 2473011418S0018. http://dx.doi.org/10.1177/2473011418s00189.

Full text
Abstract:
Category: Ankle Arthritis Introduction/Purpose: Although the frequent intraarticular pathologies associated with recurrent ankle sprains are well known, informations regarding treatment method for arthritic changes in the medial gutter are still insufficient. This study was performed to evaluate the intermediate-term clinical and radiological outcomes following modified Broström procedure and arthroscopic debridement in the middle-aged patients. Methods: Twenty-two patients with medial gutter osteoarthritis related to chronic lateral ankle instability were followed for more than 3 years after surgical treatment. All patients showed medial joint space narrowing of Takakura stage 2. The clinical evaluation consisted of the American Orthopaedic Foot and Ankle Society (AOFAS) score, visual analogue scale (VAS) for medial ankle pain during walking, and Foot and Ankle Ability Measure (FAAM). Results: Mean AOFAS and FAAM scores significantly improved from 51.2 and 45.7 points preoperatively to 80.3 and 78.4 points at final followup, respectively (P < .001). Although mean pain-VAS significantly improved from 6.8 points to 3.5 points (P < .001), 8 patients (36.4%) complained of discomfort at gait with considerable pain ≥ 4 points. There was only 1 patient (4.5%) with recurrent ankle instability, while 6 patients (27.3%) showed a progression in arthritis stage. Conclusion: Modified Broström procedure concomitant with arthroscopic debridement for medial gutter osteoarthritis secondary to chronic ankle instability is not effective enough to treat the medial ankle pain and functional impairment. Alternative treatment strategies for middle-aged cohort with arthritic changes are needed to improve the clinical outcomes and to prevent a progressive osteoarthritis.
APA, Harvard, Vancouver, ISO, and other styles
7

Dakin, Stephanie G. "Synovial signatures signpost arthritis." Science Translational Medicine 11, no. 488 (April 17, 2019): eaax1725. http://dx.doi.org/10.1126/scitranslmed.aax1725.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rasker, J. J., and J. A. Cosh. "Course and Prognosis of Early Rheumatoid Arthritis." Scandinavian Journal of Rheumatology 18, sup79 (January 1989): 45–56. http://dx.doi.org/10.3109/03009748909092612.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Paroli, M. P., S. Speranza, M. Marino, M. P. Pirraglia, and P. Pivetti-Pezzi. "Prognosis of Juvenile Rheumatoid Arthritis-Associated Uveitis." European Journal of Ophthalmology 13, no. 7 (August 2003): 616–21. http://dx.doi.org/10.1177/112067210301300704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

DE CUNTO, CARMEN L., EDWARD H. GIANNINI, CHESTER W. FINK, EARL J. BREWER, and DONALD A. PERSON. "Prognosis of children with poststreptococcal reactive arthritis." Pediatric Infectious Disease Journal 7, no. 10 (October 1988): 683–85. http://dx.doi.org/10.1097/00006454-198810000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Arthritis Prognosis"

1

Visser, Hendrik. "Diagnosis and prognosis in early arthritis /." [S.l.] : [s.n.], 2003. http://catalogue.bnf.fr/ark:/12148/cb40022155x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sreerangaiah, Dee. "Qualification of ultrasonography as a biomarker of prognosis and response to treatment in early rheumatoid arthritis." Thesis, Imperial College London, 2012. http://hdl.handle.net/10044/1/24958.

Full text
Abstract:
Objectives: to assess the value of quantitative vascular imaging by power Doppler ultrasound (PDUS) as a tool that can be used to stratify patient risk of joint damage in early seropositive RA while still biologic-naive but on synthetic DMARD treatment. Methods: 85 patients with seropositive RA <3 years duration, had clinical, laboratory and imaging assessments at 0, 6 and 12 months. Imaging assessments consisted of radiographs of hands and feet, 2 dimensional high frequency and PDUS imaging of 10 metacarpophalangeal joints (MCPJs) which were scored for erosions and vascularity, and 3 dimensional PDUS of MCPJs and wrists which were scored for vascularity. Results: Severe deterioration on radiographs and ultrasonography was seen in 45% and 28% of patients respectively. 3D PD volume and 2D vascularity scores were the most useful ultrasound predictors of deterioration. These variables were modelled in 2 equations which estimate structural damage over 12 months. The equations had a sensitivity of 63.2% and specificity of 80.9% for predicting structural damage on x-ray, and a sensitivity of 54.2% and specificity of 96.7% for predicting structural damage on ultrasound. Conclusions: In seropositive early RA, quantitative vascular imaging by PDUS has clinical utility in predicting which patients would derive benefit from early use of biologics therapy.
APA, Harvard, Vancouver, ISO, and other styles
3

Manivel, Vivek Anand. "The role of anti-collagen type II antibodies in the pathogenesis and prognosis of rheumatoid arthritis." Doctoral thesis, Uppsala universitet, Klinisk immunologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-311959.

Full text
Abstract:
Rheumatoid arthritis (RA) which affects 0.5-1% of the world population and is characterised by joint erosions and presence of the autoantibodies anti-citrullinated protein antibodies (ACPA) and rheumatoid factor. Collagen II (CII) is a joint-specific antigen and we have shown that antibodies against CII (anti-CII) are present in around 8% of RA patients. RA patients with anti-CII are characterized by acute RA onset with elevated CRP and early joint erosions at the time of RA onset. Polymorphonuclear granulocytes (PMN) and peripheral blood mononuclear cells (PBMC) are abundant in RA synovial fluids, where they can interact with anti-CII, thus forming immune complexes (IC) with CII. In my thesis I have shown that PMN upregulated the cell surface markers CD66b and CD11b and downregulated CD16 and CD32 after stimulation with anti-CII IC. These changes in CD66b and CD16 associated to joint erosions to a larger extent than did PBMC responses to anti-CII IC. PMN cocultured with PBMC and stimulated with anti-CII IC showed augmented chemokine production that was dependent on TLR4 and functionally active PMN enzymes. This mechanism can lead to accumulation of inflammatory cells in joints of RA patients who are anti-CII positive around the time of RA diagnosis, and may thus help explain the acute onset RA phenotype associated with anti-CII. In a large Swedish RA cohort, anti-CII associated with elevations in clinical and laboratory measures of disease activity at diagnosis and until 6 months, whereas ACPA associated with late inflammation. Anti-CII seropositive RA was associated with improvements in clinical measurements and was negatively associated with smoking in contrast to ACPA that was associated with worseneing of clinical symptoms and associated positively with smoking. Anti-CII levels associated to  HLADRB1*03 and  HLADRB1*01 whereas ACPA showed negative association to HLA-DRB1*03. In a Malaysian RA cohort anti-CII also associated to elevated CRP at the time of diagnosis. Anti-CII seropositive RA represents a distinct phenotype, in many respects representing the converse  to the clinical, genetic and smoking associations described for ACPA. Early determinations of anti-CII in parallel to ACPA predict the inflammatory outcome in RA.
APA, Harvard, Vancouver, ISO, and other styles
4

Dahlström, Örjan. "Focus on Chronic Disease through Different Lenses of Expertise : Towards Implementation of Patient-Focused Decision Support Preventing Disability: The Example of Early Rheumatoid Arthritis." Doctoral thesis, Linköpings universitet, Institutionen för beteendevetenskap och lärande, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-18112.

Full text
Abstract:
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory disease. Treatment strategies emphasize early multi-professional interventions to reduce disease activity and to prevent disability, but there is a lack of knowledge on how optimal treatment can be provided to each individual patient. Aim: To elucidate how clinical manifestations of early RA are associated to disease and disability outcomes, to strive for greater potential to establish prognosis in early RA, and to facilitate implementation of decision support through analyses of the decision-making environment in chronic care. Methods: Multivariate statistics and mathematical modelling, as well as field observations and focus group interviews. Results: Decision support: A prognostic tree that predicted patients with a poor prognosis (moderate or high levels of DAS-28) at one year after diagnosis had a performance of 25% sensitivity, 90% specificity and a positive predictive value of 76%. Implementation of a decision support application at a rheumatology unit should include taking into account incentive structures, workflow and awareness, as well as informal communication structures. Prognosis: A considerable part of the variance in disease activity at one year after diagnosis could be explained by disease progression during the first three months after diagnosis. Using different types of knowledge – different expertise – prior to standardized data mining methods was found to be a promising when mining (clinical) data for new patterns that elicit new knowledge. Disease and disability: Women report more fatigue than men in early RA, although the difference is not consistently significant. Fatigue in early RA is closely and rather consistently related to disease activity, pain and activity limitation, as well as to mental health and sleep disturbance. Conclusion: A decision tree was designed to identify patients at risk of poor prognosis at one year after the diagnosis of RA. When constructing prediction rules for good or poor prognosis, including more measures of disease and disability progressions showed promise. Using different types of knowledge – different lenses of expertise – prior to standardized data mining methods was also a promising method when mining (clinical) data for new patterns that elicit new knowledge.
Introduktion: Reumatoid artrit (RA) är en kronisk inflammatorisk sjukdom. Dagens behandlingsstrategi bygger på tidiga multiprofessionella insatser för att reducera sjukdomsaktivitet och minska risken för framtida funktionshinder. Idag finns stora datamängder tillgängliga gällande medicinering och utfall vid RA. Dessa data erbjuder möjligheter att generera ny kunskap som kan användas för att forma beslutsstöd. Syfte: Att undersöka hur olika kliniska manifestationer vid tidig RA samvarierar med funktionshinder och sjukdomsaktivitet, att pröva metoder att ställa prognos vid tidig RA, och att analysera en kontext för beslutsfattande inom vård av kroniskt sjuka. Metod: Multivariat statistik och matematisk modellering, samt observationsstudier och fokusgruppsintervjuer. Resultat: Beslutsstöd: Ett beslutsträd utformades för att bestämma vilka patienter som har dålig prognos (måttlig eller hög DAS-28) ett år efter diagnos. Beslutsträdet hade 25 % sensitivitet, 90 % specificitet och ett positivt prediktivt värde på 76 %. Vid införande av beslutsstöd på en reumatologisk klinik befanns det nödvändigt att hänsyn tas till incitamentsstrukturer, arbetsflöde och samarbetsformer. Informella kommunikationsstrukturer kan också ha stort inflytande på klinisk praxis. Prognos: En betydande del av variansen i sjukdomsaktivitet ett år efter diagnos kan förklaras av sjukdomsprogression första tre månaderna efter diagnos. Att formalisera olika experters erfarenheter före standardiserade ”data mining” metoder är en lovande ansats när man letar efter mönster i (kliniska) databaser. Funktionshinder och sjukdomsaktivitet: Kvinnor rapporterar mer trötthet än män vid tidig RA, men skillnaden är inte konsistent över tid. Trötthet vid tidig RA är nära relaterat till sjukdomsaktivitet, smärta och aktivitets begränsningar, men också till mental hälsa och sömnstörningar. Slutsats: Ett beslutsträd har utformats för att predicera patienter med dålig prognos inom tidig RA. Studier av fler mått på sjukdoms- och funktionshindersprogression behövs vid konstruktion av prediktionsregler för god eller dålig prognos framledes. Att använda sig av kunskap från olika experter – olika experters glasögon – vid sökandet efter mönster i stora datamängder för att generera ny kunskap är en lovande metodik. Implementering av beslutsstöd bör göras under övervägande av incitamentsstrukturer, arbetsflöde och samarbetsformer.
APA, Harvard, Vancouver, ISO, and other styles
5

Hui, Kwun-ho. "The diagnostic and prognostic value of anti-CCP assay in the juvenile idiopathic arthritis (JIA)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971817.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hui, Kwun-ho, and 許冠浩. "The diagnostic and prognostic value of anti-CCP assay in the juvenile idiopathic arthritis (JIA)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31971817.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bejarano, Victoria. "Use of novel prognostic tools, outcome measures and therapeutic strategies in early rheumatoid arthritis." Thesis, University of Leeds, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.558797.

Full text
Abstract:
Though the management of rheumatoid arthritis (RA) has recently been revolutionised, the optimal initial therapeutic regimen in the vital early stages is not known and critically the long-term effects of currently proposed regimens are not well documented. Patients with an expected poor prognosis would gain most from early treatment with highly effective but expensive new therapies; this highlights the need for better prognostic tools. Modern outcomes for RA should reflect patient expectations, for example, participation in work. In this thesis, evidence of the long-term effects of 2 initial therapeutic regimens in early RA was sought. Patients treated with an initial combination of methotrexate (MTX), ciclosporin A (CsA) and intraarticular glucocorticoids in early, poor prognosis RA required less biological agents after 7 years, compared with sulfasalazine (SSZ) monotherapy. The toxicity associated with CsA was reversible. Similarly patients that received an initial combination of infliximab plus MTX for early, poor prognosis RA had better disease control at 8 years than those who had initial MTX monotherapy. Dual energy X-ray absorptiometry (DXA) was tested as a prognostic tool in early RA given its reliability and easy availability. DXA measured hand bone loss during the first year of treatment was associated with radiographic progression at 6 years; however this did not perform better than a baseline radiograph. Imminent and actual job loss were proposed as patient reported outcomes in early RA. Patients receiving an initial combination of adalimumab plus MTX in early RA had a larger improvement in work related outcomes compared with MTX monotherapy. In summary initial therapeutic combinations in early RA can offer short and long-term benefits compared with monotherapy when measuring modern patient relevant and traditional outcomes. There is still a need for clinically useful prognostic tools in early disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Nikiforou, E. "Orthopaedic intervention in rheumatoid arthritis : a retrospective analysis of incidence, prognostic markers and costs." Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1420127/.

Full text
Abstract:
Background: Orthopaedic surgery in Rheumatoid Arthritis (RA) is an established intervention of long-term disease and a surrogate marker of joint destruction. Methods: This thesis examines orthopaedic data from the Early RA Study (1986-1999, 9 centres, n=1465) and the Early RA Network (2002-2012, 23 centres, n=1236) with linkage to national datasets (Hospital Episode Statistics, National Joint Registry and Office of National Statistics). Clinical and laboratory measures and hand and foot radiographs were standardised and performed yearly in both cohorts. Disease modifying, glucocorticosteroid and biologic therapies reflected conventional practice and guidelines of the time frames examined. Recruitment years were grouped into 6 periods, interventions classified into major, intermediate and minor categories. Cost analysis was based on the Norfolk Arthritis Register (1989-date, n>5000). Results: A total of 1602 surgical procedures were performed in 770 patients (29%). Declines in the rates of hand/foot surgery from 1986-2011 (p<0.001) coincided with secular changes in therapy. No secular variation was seen for large joint replacements. Low haemoglobin predicted shorter time to both major and intermediate surgery (p<0.001). There were declines in median length of stay over time for large, intermediate and minor procedures (8,3,1 days respectively). The mean annual direct health cost per RA patient was £3,430 (over 50% representing medications). The COI of RA in England was estimated at £1.46 billion. Conclusions: This study has compiled the largest, longest and most extensively linked RA- related orthopaedic surgery database in the UK. The declines in intermediate-type surgery during recruitment periods where early and intensive treatments were employed, suggests the impact of these treatments. The thesis demonstrates the predictive power of standard clinical measures in the first year of disease on orthopaedic surgery up to 25 years later. It demonstrates the high economic burden of RA and could be used as a basis for future cost- effectiveness and cost-benefit analyses.
APA, Harvard, Vancouver, ISO, and other styles
9

Biernath, Kristof [Verfasser]. "Bedeutung der Matrix-Metalloproteinase-3-Serum-Spiegel für die Prognose bei Patienten mit rheumatoider Arthritis / Kristof Heinrich Walter Gerald Biernath." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2015. http://d-nb.info/1079525262/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Biernath, Kristof Heinrich Walter Gerald [Verfasser]. "Bedeutung der Matrix-Metalloproteinase-3-Serum-Spiegel für die Prognose bei Patienten mit rheumatoider Arthritis / Kristof Heinrich Walter Gerald Biernath." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2015. http://d-nb.info/1079525262/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Arthritis Prognosis"

1

1950-, Bellamy Nicholas, ed. Prognosis in the rheumatic diseases. Dordrecht: Kluwer Academic Publishers, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Feist, Eugen, and Gerd-R. Burmester. Rheumatoid arthritis—clinical features. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0111.

Full text
Abstract:
Rheumatoid arthritis (RA) presents with variable clinical features, making this most frequent chronic systemic autoimmune disease with characteristic joint involvement a diagnostic and therapeutic challenge. This chapter describes in detail the different clinical, laboratory and imaging findings in patients with RA. In addition to the characteristic arthritic involvement, which can lead to severe joint changes with progressive destruction and loss of function, other systemic disease manifestations as well as an increased risk for cardiovascular events and non-Hodgkin's lymphoma with relevance for patients' prognosis are described. Recent approaches to early diagnosis and stratification of patients by predictive factors for a severe course of disease are discussed. These patient profiles include increased inflammatory markers, the presence of autoantibodies, and erosive changes at the time of diagnosis. The novel classification criteria for RA and the significance of autoantibody status, namely seropositivity for antibodies against citrullinated antigens as highly specific diagnostic markers, are highlighted to further promote early differentiation of RA from other arthritic disease entities.
APA, Harvard, Vancouver, ISO, and other styles
3

Foster, Brogan, and Paul A. Brogan. Juvenile idiopathic arthritis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198738756.003.0003.

Full text
Abstract:
This chapter describes the JIA subtypes, uveitis, prognostic indicators, the spectrum of JIA in adults and updated chapters on the genetics and immunology of JIA. There are updated sections on treatment approaches, pathways (including reference to NICE and guidance from North America and Europe) and disease activity scores.
APA, Harvard, Vancouver, ISO, and other styles
4

Deighton, Chris. Rheumatoid arthritis—management. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0112.

Full text
Abstract:
Influential guidelines on rheumatoid arthritis (RA) management agree on most key recommendations. Early diagnosis of persistent synovitis, and identification of poor prognostic markers, is essential. Rapid intervention is vital with drugs to suppress inflammation, slow down damaging disease components, and prevent disability. The label of RA covers a broad spectrum of disease severity, and there is controversy on: • whether the same interventions are needed for all patients • whether monotherapy or combination treatment is appropriate • the role of steroids in RA • the appropriate introduction of biological therapies. Treating to specified targets is optimal evidence-based practice, where patients are reviewed regularly for disease activity assessments, and inadequate control rectified. Aiming for remission is the ultimate goal, though for some patients minimal disease activity may be appropriate. Patient education addressing self-management is important, and the multidisciplinary team (MDT: specialist nurses, physiotherapists, occupational therapists, podiatrists, psychologists) needs to be involved from the start to minimize the impact on quality of life of the patient. For established disease, rapid access is important for flares, and to consider whether disease management could be improved. An intermittent overview of established disease is important with access to the MDT, and assessments for comorbidities such as ischaemic heart disease, osteoporosis, and depression, as well as complications of the disease itself such as cervical spine disease, vasculitis, and lung and eye complications. An informed patient needs to be central to all decision making.
APA, Harvard, Vancouver, ISO, and other styles
5

Watts, Richard A., and Eleana Ntatsaki. Miscellaneous vasculitides. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0137.

Full text
Abstract:
The vasculitides are a group of relatively rare conditions with a broad spectrum of clinical presentations that can cause significant morbidity and mortality. Classification of the vasculitic syndromes is done according to the size of the vessels affected and also the presence of anti-neutrophil cytoplasmic antibodies (ANCA). Vasculitides can be either primary or secondary to an underlying systemic disease, malignancy, or infection. This chapter covers the spectrum of the secondary vasculitides; some of the non-ANCA-associated primary vasculitides and miscellaneous types of vasculitic syndromes. Secondary vasculitis can occur in the background of systemic rheumatic diseases such as rheumatoid arthritis, spondyloarthropathies, or other connective tissue diseases. Vasculitis can also present in relation to precipitants such as drugs (propylthiouracil, hydralazine, leucotriene antagonists) or vaccines. Infection (bacterial, mycobacterial, viral, and fungal) has been associated with vasculitis either as a trigger or as a consequence of iatrogenic immunosuppression. Infection-related vasculitis can affect all types and sizes of vessels. Certain forms of vasculitis such as cryoglobulinaemia are closely associated with viral infections and more specifically with HCV infection. There are forms of vasculitis, which appear to be isolated or localized to a single organ, or site (skin, gastrointestinal, genital, and primary central nervous system vasculitis) that may be histologically similar to systemic syndromes, but have a different prognosis. Other conditions that may mimic vasculitis and miscellaneous conditions such as Cogan's syndrome and relapsing polychondritis are also discussed.
APA, Harvard, Vancouver, ISO, and other styles
6

Controlling progression of severe rheumatoid arthritis: New perspectives on prognostic markers and treatment : proceedings of a satellite symposium, Amsterdam, The Netherlands, 19 June 1995. Oxford: Oxford University Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hoyles, Rachel K., and Athol U. Wells. Respiratory system. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0020.

Full text
Abstract:
Pulmonary involvement is common in the connective tissue diseases (CTDs) and is associated with significant morbidity and mortality. Improved management of systemic disease has led to increasing numbers of surviving patients with clinically significant pulmonary disease. Screening for pulmonary complications highlights the frequency of subclinical involvement. In this chapter, the pulmonary manifestations of the more common CTDs are detailed, including rheumatoid arthritis (RA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), polymyositis/dermatomyositis (PM/DM), Sjögren's syndrome (SS), and, more briefly, ankylosing spondylitis (AS). A broad spectrum of pulmonary disorders are seen in association with the CTDs or the drugs used to treat the underlying disorder, including interstitial lung disease, pulmonary infections, airways disease, pulmonary nodules, pleural disease, chest wall pathology and pulmonary vascular disease; the discussion is stratified by pulmonary complication. In many cases, two or more pulmonary manifestations of CTD coexist or there are other concurrent diseases such as asthma and lung cancer, resulting in potentially confusing mixed imaging and pulmonary function abnormalities. This chapter presents a comprehensive approach to the investigation, screening, prognostic evaluation, and treatment decisions in pulmonary disease associated with the CTDs.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Arthritis Prognosis"

1

Wolfe, F. "Rheumatoid arthritis." In Prognosis in the Rheumatic Diseases, 37–82. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3896-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ansell, B. M. "Juvenile arthritis." In Prognosis in the Rheumatic Diseases, 83–96. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3896-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gladman, D. D. "Psoriatic arthritis." In Prognosis in the Rheumatic Diseases, 153–66. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3896-3_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ansell, Barbara M. "Prognosis in Juvenile Arthritis." In Rheumaderm, 27–33. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4857-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bellamy, N., R. R. Grigor, and R. P. Naden. "Arthritis in pregnancy." In Prognosis in the Rheumatic Diseases, 279–319. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3896-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ravelli, Angelo. "Outcome, Prognosis and Future Outlook." In Handbook of Juvenile Idiopathic Arthritis, 121–24. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-08102-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bhalla, Parinishtha, Anukriti Verma, Bhawna Rathi, Shivani Sharda, and Pallavi Somvanshi. "Exploring Molecular Signatures in Spondyloarthritis: A Step Towards Early Diagnosis." In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022), 142–55. Dordrecht: Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_15.

Full text
Abstract:
AbstractSpondyloarthritis is an acute inflammatory disorder of the musculoskeletal system often accompanied by pain, stiffness, bone and tissue damage. It majorly consists of ankylosing spondylitis, psoriatic arthritis and reactive arthritis. It follows a differential diagnosis pattern for demarcation between the spondyloarthritis subtypes and other arthritic subtypes such as rheumatoid arthritis, juvenile arthritis and osteoarthritis due to the heterogeneity causing gradual chronicity and complications. Presence of definite molecular markers can not only improve diagnosis efficiency but also aid in their prognosis and therapy. This study is an attempt to compose a refined list of such unique and common molecular signatures of the considered subtypes, by employing a reductionist approach amalgamating gene retrieval, protein-protein interaction network, functional, pathway, micro-RNA-gene and transcription factor-gene regulatory network analysis. Gene retrieval and protein-protein interaction network analysis resulted in unique and common interacting genes of arthritis subtypes. Functional annotation and pathway analysis found vital functions and pathways unique and common in arthritis subtypes. Furthermore, miRNA-gene and transcription factor-gene interaction networks retrieved unique and common miRNA’s and transcription factors in arthritis subtypes. Furthermore, the study identified important signatures of arthritis subtypes that can serve as markers assisting in prognosis, early diagnosis and personalized treatment of arthritis patients requiring validation via prospective experimental studies.
APA, Harvard, Vancouver, ISO, and other styles
8

Marshall, W. H., S. Drover, B. A. Larsen, D. Codner, M. D. Copp, J. Gamberg, E. Keystone, D. Gladman, and J. Wade. "Assessing Prognosis in Rheumatoid Arthritis Using Monoclonal Antibodies and Flow Cytometry." In Immunogenetics: Advances and Education, 87–98. Dordrecht: Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5486-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schneider, M., M. Lelgemann, H. H. Abholz, M. Blumenroth, C. Flügge, M. Gerken, H. Jäniche, et al. "Diagnose und Prognose der frühen rheumatoiden Arthritis (RA)." In Interdisziplinäre Leitlinie, 5–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-23269-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gladman, Dafna D., Cheryl F. Rosen, and Vinod Chandran. "Prognosis." In Psoriatic Arthritis, 87–92. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199692095.003.0013.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Arthritis Prognosis"

1

YAMAUCHI, Morio, Kazuhisa NAKANO, Yoshiya TANAKA, and Keiichi HORIO. "Predicting Disease Activity for Biologic Selection in Rheumatoid Arthritis." In 9th International Conference on Signal, Image Processing and Pattern Recognition (SPPR 2020). AIRCC Publishing Corporation, 2020. http://dx.doi.org/10.5121/csit.2020.101913.

Full text
Abstract:
In this article, we implemented a regression model and conducted experiments for predicting disease activity using data from 1929 rheumatoid arthritis patients to assist in the selection of biologics for rheumatoid arthritis. On modelling, the missing variables in the data were completed by three different methods, mean value, self-organizing map and random value. Experimental results showed that the prediction error of the regression model was large regardless of the missing completion method, making it difficult to predict the prognosis of rheumatoid arthritis patients.
APA, Harvard, Vancouver, ISO, and other styles
2

Kocakaya, Derya, Aysun Aksoy, Yasemin Yalçınkaya, Nevsun Inanç, Emel Eryüksel, and Sait Karakurt. "Cavitary nodules in rheumatoid arthritis patients and their prognosis." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Denis, A., C. Regnier, M. Henket, N. Maes, M. Thys, R. Louis, M. Malaise, and J. Guiot. "Airflow obstruction as a marker of prognosis in rheumatoid arthritis." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Meissner, Y., M. Schäfer, B. Manger, M. Zänker, W. Ochs, J. Listing, and A. Strangfeld. "THU0142 The prognosis of heart failure in patients with rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3979.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jung, S. Y., J. J. choi, and S. K. lee. "AB1217 Fluorometric imaging for early diagnosis and prognosis of rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.5339.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hyldgaard, Charlotte, Anders Løkke, Alma Becic Pedersen, Sinna Pilgaard Ulrichsen, Ole Hilberg, Elisabeth Bendstrup, and Torkell Ellingsen. "Prognosis in rheumatoid arthritis patients with COPD: A nationwide, registry-based study." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.oa1786.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Assefnia, Shahin, Sivanesan Dakshanamurthy, Jaime M. Guidry Auvil, Constanze Hampel, Panos Anastasiadis, Bhaskar Kallakury, Aykut Uren, et al. "Abstract A045: Cadherin-11, a common therapeutic target in poor prognosis malignancies and rheumatoid arthritis." In Abstracts: AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications - October 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1557-3125.advbc-a045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ziade, Nelly, Amani Daher, Bassel Zorkany, Samar Al Emadi, Hussein Halabi, Mohammad Abu Jbara, Lina Kibbi, et al. "THU0108 11. RHEUMATOID ARTHRITIS – PROGNOSIS, PREDICTORS AND OUTCOME CONCORDANCE BETWEEN PHYSICIAN AND PATIENT ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING DISEASE ACTIVITY SCORE." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Reyes, Felipe, Silvana Saavedra, Karen Vergara, Matias Florenzano, and Veronica Wolff. "Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3481.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kato, Go, Koichiro Takahashi, Kohei Nagawasa, Sinya Kimura, and Shinichiro Hayashi. "Honeycomb Dominant- And Ground Glass Opacity/Reticular Shadow Dominant-Interstitial Lung Disease Are Associated With A Good Prognosis In Rheumatoid Arthritis." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2363.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Arthritis Prognosis"

1

Inina, L. I., and M. M. Ivanova. PROGNOSTIC SIGNIFICANCE OF CERTAIN CLINICAL FINDINGS IN PATIENTS WITH YERSINIA ARTHRITIS. Планета, 2018. http://dx.doi.org/10.18411/978-5-907109-24-7-2018-xxxiv-74-75.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Arthritis Prognosis' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography